Table 2.
n | Prevalence (%) [95% CI] | Median age (Yrs) [IQR] | Median CD4 count (cells/mm3) [IQR] | |
---|---|---|---|---|
Normal Smears | 1,439 | 61.9 [59.9 – 63.9] | 32.3 [28.2 – 37.6] | 351 [191 – 531] |
Pre-malignant Lesions (ALL) | 886 | 38.1 [36.1 – 40.1] | 31.9 [27.7 – 36.4] | 254 [136 – 401] |
ASCUS | 73 | 3.1 [2.4 – 3.8] | 29.3 [25.4 – 34.7] | 265 [175 – 504] |
LSIL | 474 | 20.4 [18.7 – 22.0] | 31.6 [27.1 – 36.0] | 273 [144 – 406] |
ASCH | 23 | 1.0 [0.6 – 1.4] | 33.9 [27.1 – 37.0] | 263 [155 – 463] |
HSIL | 315 | 13.5 [12.1 – 14.9] | 32.9 [29.2 – 37.3] | 229 [125 – 374] |
AGUS | 1 | 0.0 [0 – 0.1] | 26.5 [ -- ] | 115 [ -- ] |
Cancer | 0 | -- | -- | -- |
ASCUS – atypical cell of uncertain significance; LSIL – low grade intraepithelial lesion, ASCH – atypical cells cannot exclude HSIL; HSIL – high grade squamous intraepithelial lesion; AGUS – atypical glandular cells of uncertain significance.